Hapioneer announced that it has received $8,200,000 in angel round of funding led by Shandong Sanyuan Biotechnology Co.,Ltd. on October 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.5 CNY | +6.77% | +14.76% | +12.53% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.53% | 910M | |
-4.79% | 2.97B | |
-3.48% | 1.9B | |
+0.51% | 1.84B | |
-0.18% | 1.17B | |
-12.41% | 1.07B | |
+2.22% | 998M | |
-9.39% | 904M | |
+0.48% | 902M | |
+3.50% | 826M |
- Stock Market
- Equities
- 301206 Stock
- News Shandong Sanyuan Biotechnology Co.,Ltd.
- Hapioneer announced that it has received $8.200000 million in funding from Shandong Sanyuan Biotechnology Co.,Ltd. and other investors.